Paul DeJong is done for 2026, and A.J. Hinch's Tigers just lost a veteran power bet before it ever had a chance to matter.
That is the hard turn here. DeJong is set for season-ending hamstring surgery after a brief run in Detroit's system, ending any shot at a midyear climb back to the majors.
The timing makes it sting more. DeJong had only recently signed a minor league deal with the Tigers, giving the club a low-cost infield power option with real big-league experience.
Instead, the move is already dead for this season. DeJong was placed on the full-season injured list at Triple-A Toledo before the full picture came out, and the hamstring issue turned out to be serious enough to require surgery.
That wipes out a comeback path that was starting to take shape. DeJong had appeared in 29 games for Toledo and hit .188 with 6 home runs before the injury shut everything down.
For Detroit, this is not a franchise-breaking loss. But it does erase one of those depth swings clubs like to keep close when the infield starts getting thin in the second half.
-
Why this Paul DeJong setback still matters
DeJong is not far removed from being a useful major-league piece, and that is what gave this Tigers deal some appeal. A former All-Star with pull-side power can still force his way into a picture if the bat gets hot.
That is also why the injury lands with some weight in Toronto circles. DeJong had his short Blue Jays stop in 2023, and even if it did not last, his right-handed pop was still the carrying tool that kept getting him chances elsewhere.
The problem now is much simpler. Hamstring surgery does not leave room for a quick reset or a fast roster return. Once that decision is made in late May, the season is basically gone.
Detroit also loses a possible call-up bat. DeJong was never guaranteed anything with the Tigers, but veteran depth matters over a long summer when clubs start burning through options and bench pieces.
For DeJong himself, this is another brutal interruption in a career that has already asked for too many restarts. He went from trying to hit his way back into a roster conversation to rehabbing for 2027.
That is the part that sticks. The Tigers were not counting on Paul DeJong to carry anything, but they did give him a lane, and surgery closed it before the story could go anywhere.
So the headline is blunt because the outcome is, too. Former Blue Jays slugger Paul DeJong will not get a late push, a roster chance, or a second-half shot with Detroit this year. He is done for the season.
Will Paul DeJong get another real MLB chance after this surgery?
Also read on Blue Jays Insider :
Jamie Campbell fires back at Cam Schlittler after Blue Jays jab
